# vTv Therapeutics Inc.: Form SCHEDULE 13D/A, filed Sep 3, 2025

- Company: [vTv Therapeutics Inc.](/companies/vtvt.md) (CIK 1641489)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-03
- Accepted by EDGAR: Sep 3, 2025, 19:33 ET
- Period: not reported
- Accession: 0001415889-25-023605
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1641489/000141588925023605/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641489/000141588925023605/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641489/000141588925023605/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-023605. Last ingested by Listed: Nov 5, 2026, 18:36 ET. No prices; not investment advice.